ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,536, issued on May 20, was assigned to MESOBLAST INTERNATIONAL SARL (Meyrin, Switzerland).
"Method for treating heart failure" was invented by Silviu Itescu (Melbourne, Australia) and Lee Golden (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating chronic heart failure due to left ventricular end systolic (LVESV) dysfunction with STRO-1+ mesenchymal linage precursor cells (MPCs) are provided."
The patent was filed on May 17, 2023, under Application No. 18/318,877.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%...